Literature DB >> 30238129

[Anesthesia in patients with NBIA : Neurodegeneration with brain iron accumulation].

T Warnecke1, J Schmitz2, S Kerkhoff2, J Hinkelbein2.   

Abstract

BACKGROUND: Neurodegeneration with brain iron accumulation (NBIA) forms a group of rare hereditary diseases with rapid neurodegenerative progression due to an abnormal accumulation of iron in the basal ganglia. This causes extrapyramidal symptoms as well as dystonia and mental retardation. The most common form of NBIA is pantothenate kinase-associated neurodegeneration (PKAN, formerly Hallervorden-Spatz syndrome). There are multiple anesthesiological challenges with great implications for the clinical routine, particularly regarding the preparation for general anesthesia and the premedication visits. As with other orphan diseases, the available recommendations are mainly based on case reports. OBJECTIVE AND METHODS: This article gives a short overview of complications associated with NBIA pertaining to general anesthesia. This includes anesthesia-relevant clinical symptoms and perioperative management. The published literature and case reports (available on PubMed) were reviewed to extract a set of recommendations.
RESULTS: So far only a few reports have included the anesthesia management of NBIA patients. Most of them refer to PKAN as the predominant type (50% of cases). Recommendations were found on www.orphananesthesia.eu and consensus guidelines on PKAN in general. In particular, dystonia-related restrictions in the maxillofacial area can complicate airway management and cause difficulties with respect to intubation. Furthermore, local or regional anesthesia as the sole anesthesia technique is not eligible/viable due to the reduced compliance of the patient. Special attention should be paid to a timely premedication visit and evaluation to ensure sufficient time to safely plan and prepare the anesthetic procedure.
CONCLUSION: The handling of NBIA patients requires good preparation, including an interdisciplinary team and customized time management. In principle, both general anesthesia as a balanced method and total intravenous anesthesia (TIVA) seem to be possible/viable options. The main focus is on airway management. Even after brief sedation in the context of diagnostic measures, the patient should be monitored for longer than usual.

Entities:  

Keywords:  Anesthesia management; Hallervorden-Spatz syndrome (HSS); Neurodegeneration with brain iron accumulation (NBIA); Orphan disease; Pantothenate kinase-associated neurodegeneration (PKAN)

Year:  2018        PMID: 30238129     DOI: 10.1007/s00101-018-0488-4

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  20 in total

1.  Self-inflicted injury in a case of Hallervorden-Spatz disease.

Authors:  E C Sheehy; P Longhurst; D Pool; M Dandekar
Journal:  Int J Paediatr Dent       Date:  1999-12       Impact factor: 3.455

2.  Dexmedetomidine for a patient with Hallervorden-Spatz syndrome during magnetic resonance imaging: a case report.

Authors:  B Madhusudhana Rao; M Radhakrishnan
Journal:  J Anesth       Date:  2013-06-14       Impact factor: 2.078

3.  Intraventricular baclofen as an alternative to intrathecal baclofen for intractable spasticity or dystonia: outcomes and technical considerations.

Authors:  Michael Turner; Ha Son Nguyen; Aaron A Cohen-Gadol
Journal:  J Neurosurg Pediatr       Date:  2012-08-03       Impact factor: 2.375

4.  Anesthesia for patients with pantothenate-kinase-associated neurodegeneration (Hallervorden-Spatz disease) - a literature review.

Authors:  Jochen Hinkelbein; Armin Kalenka; Markus Alb
Journal:  Acta Neuropsychiatr       Date:  2006-06       Impact factor: 3.403

5.  Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration.

Authors:  Anil Rana; Erwin Seinen; Katarzyna Siudeja; Remco Muntendam; Balaji Srinivasan; Johannes J van der Want; Susan Hayflick; Dirk-Jan Reijngoud; Oliver Kayser; Ody C M Sibon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

6.  Staged bilateral stereotactic pallidothalamotomy for life-threatening dystonia in a child with Hallervorden-Spatz disease.

Authors:  Istvan Balas; Norbert Kovacs; Katalin Hollody
Journal:  Mov Disord       Date:  2006-01       Impact factor: 10.338

Review 7.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

8.  Anaesthetic management of a child with panthothenate kinase-associated neurodegeneration.

Authors:  Renu Sinha; Ghansham Biyani; Sulagna Bhattacharjee
Journal:  Indian J Anaesth       Date:  2015-01

9.  Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments.

Authors:  Saeed Razmeh; Amir Hassan Habibi; Maryam Orooji; Elham Alizadeh; Karim Moradiankokhdan; Behroz Razmeh
Journal:  Neurol Int       Date:  2018-04-04

10.  Anesthetic approach to patient with Down syndrome and Hallervorden-Spatz disease who underwent tooth extraction.

Authors:  Ayşe Hande Arpaci; Poyzan Bozkurt; Özün Karaahmetoğlu
Journal:  J Res Med Sci       Date:  2015-08       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.